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Background: The relationship between congenital hypothyroidism (CH) and multiple pregnancy has not been fully
studied in Japan.
Methods: Complete nationwide data of assisted reproductive technology (ART) in Japan from 2005 to 2009
presented by the Japan Society of Obstetrics and Gynecology, which include information on CH and birth defects
were used for analyses. Diseases were reclassified according to the International Classification of Diseases, tenth
edition (ICD-10, 2003 version). The relative risk (RR) and 95% confidence interval (CI) of the incidence rate for CH
was calculated with singletons as the reference group. Additional birth defects with CH were examined. The
probandwise concordance rate of multiples and recurrence risk ratio were calculated.
Results: There were 18 patients with CH, consisting of 12 singletons and 6 multiples. The incidence rates of CH per
1,000 live births in singletons and multiples are 0.14 (=12/87,145) and 0.31 (=6/19,533), respectively. The incidence
rate was more than twofold higher in multiple births than in singleton births, but the difference was not statistically
significant (RR=2.2, 95% CI 0.8–5.9). Additional birth defects were present in three patients with CH (17%=3/18). The
multiples were affected by other birth defects more frequently (33%=2/6) than the singletons (8%=1/12). The six
multiple-births patients were derived from one concordant twin pair, which consisted of two twin patients; three
discordant twin pairs, which consisted of three twin patients; and one discordant triplets set, which consisted of
one triplet patient. Thus, the probandwise concordance rate was 33.3% (=2/(2+4)). The estimated recurrence risk
ratio was 1976 (for the total ART population) or 609 (for the Japanese general population).
Conclusions: CH was more frequent in multiples compared to singletons. A higher percentage of additional birth
defects was also observed in multiples compared to singletons. The familial aggregation of CH was suggested.
Keywords: Congenital hypothyroidism, Assisted reproductive technology, Multiple births, Live births, Epidemiologic
study, Incidence rate, Concordance rate, Recurrence risk ratio, Familial aggregationBackground
Congenital hypothyroidism (CH) is defined as thyroid
hormone deficiency present at birth and is classified into
permanent and transient CH [1]. An exact cause for the
vast majority of cases of CH (or thyroid dysgenesis)
remains unknown [1]. CH is a relatively common con-
genital disorder, occurring in about 1 of 1,500 to 4,000 live
births [2-4]. The incidence rate of CH has been reported
to be increasing [1,5,6]. The reasons for the increasedCorrespondence: sooki@ishikawa-nu.ac.jp
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reproduction in any medium, provided the orincidence rate are not clear, but several possibilities have
been pointed out, including a change in the screening test
cutoff point [2], enhanced detection [5], the increase of
preterm infants [1], and the misclassification of some
cases of transient CH as permanent CH [7].
Several risk factors of CH have been presented in
epidemiologic studies. Females are consistently reported
to more frequently suffer from CH than males [1,8]. The
association between birth weight and CH was reported to
show a U-shaped curve [9]. According to a population-
based case–control study in Italy by Medda et al. [10], the
statistically significant risk factors for permanent CH weres is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tional age >40 weeks. Using the same CH registry, Olivieri
et al. [11] showed that the incidence rate of CH in
multiples was more than 3-fold higher compared to
singletons. Another population-based study in the U.S.
also showed that the incidence rates of CH in twins
doubled as compared to that in singletons, and the inci-
dence rate was even higher with triplets/+ [6]. Moreover,
many studies reported a higher incidence rate of extra-
thyroidal additional birth defects among neonates with
CH compared with the general population [8,12-24], espe-
cially congenital heart disease [8,14,17,21-25].
Many case studies showed that CH occurs sporadically
[26], although dyshormonogenic cases are often reces-
sively inherited, and recent cohort analyses estimated
that approximately 2% of cases with thyroid dysgenesis are
familial [27,28]. Olivieri et al., in the only population-
based twin study published to date [11], noted that the
pairwise concordance rate of twin pairs for permanent CH
was low (4.3%).
Given these circumstances, assisted reproductive tech-
nology (ART) data present a unique opportunity for twin
study [29]. The percentage of multiple births among the
ART population is much higher than that in the general
population. Most twins after ART are dizygotic (DZ)
siblings that develop together in the same womb. Thus,
the aim of the present study was to compare the incidence
rate of CH in multiples with singletons, examine add-
itional birth defects with CH, and analyze the familial ag-
gregation of CH using nationwide data on ART in Japan.Materials and methods
Outline of Japanese birth defects data after ART
The method for collecting data is described in detail else-
where [29]. Almost all medical institutions performing
ART, which does not include simple ovulation stimulation/
enhancement, are registered with the Japan Society of
Obstetrics and Gynecology (JSOG). The JSOG administers
questionnaire surveys for these medical institutions. Some
of the survey data are presented in simple annual reports
of aggregate, not individual, data. The individual list of all
ART pregnancies resulting in congenital diseases, not all
ART pregnancies, is presented every year in the JSOG an-
nual reports on ART (in Japanese). The presented items
are method of treatment, blastocyst transfer, maternal age,
perinatal outcome and the gestational week, plurality, sex,
early neonatal infant death up to day 6, and name of con-
genital disease.
The author used case reports on birth defects or
congenital anomaly data from 2005–2009 as the initial
information for the present secondary data analyses. The
mean response rate throughout the 5 years was 99.0%
(3,026/3,056), meaning that almost a complete databasereflecting the current situation of ART in Japan could be
constructed.
All live births after ART were analyzed in the present
study. The types of defects were reclassified according to
the International Classification of Diseases, tenth edition
(ICD-10, 2003 version). Diseases that were classified in
the category of ICD-10 code Q00-Q99 (i.e., congenital
malformations, deformations, and chromosomal abnor-
malities) were regarded as birth defects in the present
study. CH was classified as part of E00 (congenital iodine-
deficiency syndrome) or E03 (other hypothyroidism). The
present data did not allow the author to distinguish be-
tween permanent CH and transient CH. Thus, all types of
CH were treated as CH in the present study. The total
number of ART live births, singletons and multiples, were
available from 2007 to 2009. The author estimated the
number of ART singletons and multiples between 2005
and 2006 using approximation formulae [29].
Statistical analyses
All patients with CH were listed with their obstetric data
and neonatal outcome to further examine the features of
CH patients. The frequency of additional birth defects in
neonates with CH was calculated. Next, the relative risk
(RR: the incidence rate of multiples/singletons) with the
corresponding 95% confidence interval (CI) was calculated
with singletons as the reference group.
Finally, the familial aggregation of CH was analyzed.
The probandwise concordance rate [30] was calculated.
The probandwise concordance rate is in a restricted sense
the probability that a twin is affected given that his/her
co-twin is affected. These rates can be compared directly
to risk rates reported for other familial pairings and to
population incidence rate figures [30]. Probandwise con-
cordance rates were calculated as 2×C/(2×C+D), assuming
complete and double ascertainment, where C denotes
the number of affected concordant pairs and D denotes
the number of discordant pairs [30]. For the triplets, the
neonates were counted as concordant only when all neo-
nates have CH in the present study.
A widely used measure of familial aggregation is the
sibling recurrence risk ratio (RRR), defined as the ratio
of the risk of disease manifestation, given that one’s sib-
ling is affected, compared with the disease incidence rate
in the general population [31,32]. The probandwise con-
cordance rate of multiple births was divided by the inci-
dence rate of the CH in the total ART population or the
Japanese general population in this study.
Statistical analysis was conducted using Microsoft
Excel 2010 and SAS for Windows ver. 9.2.
Results
Demographic and perinatal outcome data of all neonates
with CH are presented in Table 1. There were 18 patients














1 24 FET no 37 singleton male no
2 39 IVF no 25 triplet discordance female no
3 33 IVF yes 41 singleton male unknown
4 39 ICSI no unknown singleton male unknown
5 31 ICSI yes 35 twin discordance male no hypospadias
6 31 FET no 27 twin concordance male no
7 31 FET no 27 twin concordance male no patent ductus arteriosus
8 30 IVF no 39 singleton male unknown
9 33 ICSI yes 40 singleton female no
10 37 FET yes 40 singleton female no
11 28 ICSI no 39 singleton female no cleft lip, congenital
genu recurvatum
12 40 FET yes 41 singleton female no
13 36 IVF no 36 twin discordance male no
14 29 ICSI no 34 twin discordance female no
15 39 IVF, ICSI yes 36 singleton female no
16 38 ICSI no 40 singleton female no
17 41 FET yes 37 singleton male no
18 33 FET yes 37 singleton female no
CH: congenital hypothyroidism, ART: assisted reproductive technology, FET: frozen embryo transfer, IVF: in-vitro fertilization, ICSI: intracytoplasmic sperm injection.
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percentages of preterm delivery in singletons and multiples
were 9% (=1/11) and 100% (=5/5), respectively. The sex
ratio was 1 (9 males and 9 females). Additional birth defects
were present in three patients with CH (17%=3/18).
Multiples were more frequently affected by other birth
defects (33%=2/6) than singletons (8%=1/12). The authors
of previous studies noted that patent ductus arteriosus
(PDA) is related to prematurity and is consequently more
prevalent in twins [33,34]. When the frequency was
calculated by excluding PDA, the result was 11% (=2/18).
Multiples were also more frequently affected by other birth
defects (17%=1/6) than singletons (8%=1/12).
The incidence rate of CH per 1,000 live births was
0.17 (=18/106,678). The rate of CH was more than two-
fold higher in multiple births (0.31‰=6/19,533) than
singleton births (0.14‰=12/87,145), but the difference
was not statistically significant (RR=2.2, 95% CI 0.8–5.9).
The proportion of multiple births observed in the CH
patients (33%=6/18) was twofold higher than that
estimated in the total ART population (18%=19,533/
106,678) in the same period (2005–2009).
The calculated concordance rate and RRR are
presented in Table 2. Six multiple-births patients were
derived from one concordant twin pair, which consisted
of two twin patients; three discordant twin pairs, which
consisted of three twin patients; and one discordanttriplets set, which consisted of one triplet patient. Thus,
the probandwise concordance rate was 33.3% (=(2×1)/
(2×1+4)). The estimated RRR was 1976 for the total
ART population or 609 for the general Japanese
population.
Discussion
Incidence rate and RR
To my knowledge, there has been no published study in
which the authors directly analyzed the effect of ART on
CH. CH incidence rate in developed countries is usually
estimated by the data from neonatal screening tests,
which are performed after birth. The incidence rate of
CH noted in the present study is lower than that noted
in many other studies published recently. A neonatal
screening test for CH has been mandatory in Japan since
1979. According to the Japanese data on CH, the mean
incidence rate of CH was 1/3,600 between 1979 and
2004, and 1/2,000 in 2005, and it then increased slightly to
1/1,800 in 2009 (presented by the Japan Child and Family
Research Institute, http://www.boshiaiikukai.jp/img/milk/
kensajokyoH22.pdf (In Japanese). Accessed December 23,
2012). The lower incidence rate of CH in the present
study might be attributed to the incomplete reporting.
The follow-up period of the present data did not necessar-
ily reflect the result of the mass screening test. Moreover,
some obstetricians might not regard CH as a birth defect
Table 2 Concordance rate and RRR of CH, 2005-2009







rate (‰) (Y)pair (N) pair or set (N)
1 4 33.3 18 0.17 1976 2956 0.55 609
RRR: recurrence risk ratio, CH: congenital hypothyroidism, ART: assisted reproductive technology.
RRR was calculated probandwise concordance rate divided by the incidence rate in the general population.
The incidence rate in the Japanese general population was calculated using the data presented by the Japan Child and Family Research Institute (http://www.
boshiaiikukai.jp/img/milk/kensajokyoH22.pdf (In Japanese). Accessed December 23, 2012). The prevalence throughout 2005–2009 was 0.55‰ (=2,956/5,398,934).
Probandwise concordance rate was calculated as 33.3%=2/(2+4).
RRR for total ART population was calculated as 1976=(2/6)/(18/106,678).
RRR for Japanese general population was calculated as 609=(2/6)/(2,956/5,398,934).
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theless, the objective of this study was to evaluate the
incidence rate of CH in multiple births compared to
singletons, and not to compare the CH incidence rate
across different populations. Therefore, the comparison of
CH in multiple births and singletons maybe biased only if
there is differential reporting according to plurality, which
is not likely to have occurred.
In the present study, the incidence rate of CH in
multiples was about twofold higher than singletons, and
even though the difference was not statistically significant,
the finding suggests that multiple birth is one of the risk
factors of CH. According to the recent population-based
case control study by Medda et al. [10], an increased risk
for permanent CH was detected in twins by a multivariate
analysis (RR=12.2, 95% CI 2.4–62.3). According to the
Harris and Pass study in New York [6], the incidence of
CH was nearly double in twin births (1:876) as compared
to singletons (1:1765) and even higher with triplets/+
(1:575) in 2002–2003. According to the population-based
study by Olivieri et al. [11], a more than 3-fold higher fre-
quency of multiples was found in the CH population (10.1
in 10,000) than in the general population (3.2 in 10,000
live births). As is well known, multiple births occur far
more often in ART than in cases of spontaneous concep-
tion in almost all developed countries [29]. The multiple-
birth rate (per 1,000 live births) was increased nearly
doubled (12.4 in 1986 and 22.7 in 2005) in Japan, mainly
due to iatrogenic multiple births of advanced-age mothers
[29]. Thus, the widespread use of fertility treatment, in-
cluding ART, might in part have contributed to the rise in
the total incidence rate of CH in the general population,
by indirectly increasing multiple births. Unfortunately, the
present results did not reflect this hypothesis.
Additional birth defects
Many studies [8,12-23] reported that the frequencies of
additional birth defects with CH were between 8% and
20%, except that of a recent study by Reddy (59%) [24].
The present result (17%) was well within this range. The
present results also suggested that this tendency is more
obvious in multiples than in singletons. The mechanismof a higher frequency of additional birth defects in
patients with CH was unclear. Olivieri et al. [11] pro-
posed the hypothesis that genes involved in the develop-
ment of the thyroid and other organs may be affected
during the early stages of embryogenesis. However, it
should be noted with caution that permanent CH
showed a lower frequency of additional birth defects
than did transient CH [18].
It has been well established that congenital heart dis-
ease is the most frequently occurring additional birth de-
fect in patients with CH [8,14,17,21-25]. In the present
study, PDA was found in one twin. A recent study by
Reddy et al. [24] reported that two out of ten patients
had PDA in addition to CH. Other birth defects with
CH in the present patients were hypospadias, cleft lip,
and congenital genu recurvatum. Olivieri et al. [22]
performed a population-based study of the frequency of
additional birth defects in patients with CH. Cleft lip,
urological malformation, and musculoskeletal anomalies
were reported as additional birth defects in patients with
CH, although the numbers were small [22]. The present
results might be supported by these findings.
Familial aggregation
There have been few genetic epidemiologic studies on
CH. Family study is a useful tool to show familial aggre-
gation. Intensive family studies on CH were performed
by a French group [27,28,35] who found that appro-
ximately 2% of CH cases with thyroid dysgenesis were
familial. Although familial cases represent a minority of
cases of CH caused by thyroid disgenesis, such cases
were observed in more than 15-fold higher proportion
than would be expected from chance alone, suggesting
genetic factors.
Apart from case reports, the only population-based
twin study was performed by Olivieri et al. [11]. Ac-
cording to their study, the pairwise concordance rate of
twin pairs with unknown zygosity for permanent CH
was low (4.3%=3/70) and was due to there being three
pairs. They suggested that the sporadic occurrence of
CH was likely due to noninheritable postzygotic events
that may have included epigenetic modifications and
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tion because their calculation was based on a pairwise,
not probandwise method. The probandwise concordance
rate of their data was recalculated as 8.2% (=6/73). This
value would be compared with the incidence rate in the
general population, or would be calculated according to
the zygosity of twin pairs. Using the probandwise con-
cordance rate and their incidence rate in the general
population (0.032% in singletons), the RRR of twins was
256, which might be high enough to suggest familial ag-
gregation. Olivieri et al. [11] also found a high recur-
rence risk (35.4) for CH in siblings of affected babies
and indicated that environmental risk factors may act as
a trigger in persons with a susceptible genetic back-
ground. There was one concordant pair in the present
study, which produced a relatively high probandwise con-
cordance rate (33.3%) and RRR. Although the present
concordance rates and RRR were influenced by chance
factors, familial aggregation of CH was suggested.
Population-based twin study using univariate/multi-
variate genetic analyses based on the structural equation
modeling is the most powerful tool to clarify the gen-
etic/environmental contribution to CH and comorbidity
with other birth defects [36]. Record linkage between a
mass screening registry of CH and twin registry would
make this possible.
Limitations
This study has the following limitations, most of which
could be attributed to the dataset, based on the fact that
individual information was obtained only from the
subjects with birth defects and/or CH after ART, not the
total ART live births. The first limitation is that the au-
thor could not check the reliability of the data directly.
This is the essential limitation of secondary data analyses.
Second, although the present dataset was from a multi-
year nationwide survey, it still did not have sufficiently
high statistical power to detect statistical significance.
Third, the author could not control for confounding
factors that can affect ART and/or CH. Fourth, follow-up
after birth was limited to the neonatal period at the latest,
and was incomplete [29]. Both CH and some birth defects
are not obvious within a few days after birth. Fifth, the CH
could not be distinguished between permanent and transi-
ent type. From the view of disease prevention, all types of
CH should be properly followed up. This problem should
also be discussed from the viewpoint of medical econom-
ics for mass screening of CH.
Conclusions
CH was more frequent in multiples compared to
singletons. A higher percentage of additional birth defects
was also observed in multiples compared to singletons.
The familial aggregation of CH was suggested.Abbreviations
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